Aerovate Therapeutics
AVTE
#9017
Rank
โ‚ฌ73.71 M
Marketcap
2,55ย โ‚ฌ
Share price
1.92%
Change (1 day)
-80.78%
Change (1 year)

Aerovate Therapeutics (AVTE) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚ฌ16.59 Million

According to Aerovate Therapeutics's latest financial reports the company's total liabilities are โ‚ฌ16.59 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aerovate Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚ฌ7.97 M206.8%
2021-12-31โ‚ฌ2.6 M-82.29%
2020-12-31โ‚ฌ14.68 M129.81%
2019-12-31โ‚ฌ6.38 M